624 related articles for article (PubMed ID: 16705124)
1. Statin use and breast cancer: prospective results from the Women's Health Initiative.
Cauley JA; McTiernan A; Rodabough RJ; LaCroix A; Bauer DC; Margolis KL; Paskett ED; Vitolins MZ; Furberg CD; Chlebowski RT;
J Natl Cancer Inst; 2006 May; 98(10):700-7. PubMed ID: 16705124
[TBL] [Abstract][Full Text] [Related]
2. Lipid-lowering drug use and breast cancer in older women: a prospective study.
Cauley JA; Zmuda JM; Lui LY; Hillier TA; Ness RB; Stone KL; Cummings SR; Bauer DC
J Womens Health (Larchmt); 2003 Oct; 12(8):749-56. PubMed ID: 14588125
[TBL] [Abstract][Full Text] [Related]
3. Statin drugs and risk of advanced prostate cancer.
Platz EA; Leitzmann MF; Visvanathan K; Rimm EB; Stampfer MJ; Willett WC; Giovannucci E
J Natl Cancer Inst; 2006 Dec; 98(24):1819-25. PubMed ID: 17179483
[TBL] [Abstract][Full Text] [Related]
4. The association between statins and cancer incidence in a veterans population.
Farwell WR; Scranton RE; Lawler EV; Lew RA; Brophy MT; Fiore LD; Gaziano JM
J Natl Cancer Inst; 2008 Jan; 100(2):134-9. PubMed ID: 18182618
[TBL] [Abstract][Full Text] [Related]
5. Statins and cancer risk.
Karp I; Behlouli H; Lelorier J; Pilote L
Am J Med; 2008 Apr; 121(4):302-9. PubMed ID: 18374689
[TBL] [Abstract][Full Text] [Related]
6. Estrogen receptor-negative breast cancer is less likely to arise among lipophilic statin users.
Kumar AS; Benz CC; Shim V; Minami CA; Moore DH; Esserman LJ
Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1028-33. PubMed ID: 18463402
[TBL] [Abstract][Full Text] [Related]
7. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
[TBL] [Abstract][Full Text] [Related]
8. Serum lipids, lipid-lowering drugs, and the risk of breast cancer.
Eliassen AH; Colditz GA; Rosner B; Willett WC; Hankinson SE
Arch Intern Med; 2005 Oct; 165(19):2264-71. PubMed ID: 16246993
[TBL] [Abstract][Full Text] [Related]
9. Cholesterol-lowering drugs and colorectal cancer incidence in a large United States cohort.
Jacobs EJ; Rodriguez C; Brady KA; Connell CJ; Thun MJ; Calle EE
J Natl Cancer Inst; 2006 Jan; 98(1):69-72. PubMed ID: 16391373
[TBL] [Abstract][Full Text] [Related]
10. Continuing outcomes relevant to Evista: breast cancer incidence in postmenopausal osteoporotic women in a randomized trial of raloxifene.
Martino S; Cauley JA; Barrett-Connor E; Powles TJ; Mershon J; Disch D; Secrest RJ; Cummings SR;
J Natl Cancer Inst; 2004 Dec; 96(23):1751-61. PubMed ID: 15572757
[TBL] [Abstract][Full Text] [Related]
11. Dietary fat and postmenopausal invasive breast cancer in the National Institutes of Health-AARP Diet and Health Study cohort.
Thiébaut AC; Kipnis V; Chang SC; Subar AF; Thompson FE; Rosenberg PS; Hollenbeck AR; Leitzmann M; Schatzkin A
J Natl Cancer Inst; 2007 Mar; 99(6):451-62. PubMed ID: 17374835
[TBL] [Abstract][Full Text] [Related]
12. Prior hormone therapy and breast cancer risk in the Women's Health Initiative randomized trial of estrogen plus progestin.
Anderson GL; Chlebowski RT; Rossouw JE; Rodabough RJ; McTiernan A; Margolis KL; Aggerwal A; David Curb J; Hendrix SL; Allan Hubbell F; Khandekar J; Lane DS; Lasser N; Lopez AM; Potter J; Ritenbaugh C
Maturitas; 2006 Sep; 55(2):103-15. PubMed ID: 16815651
[TBL] [Abstract][Full Text] [Related]
13. Fracture risk among breast cancer survivors: results from the Women's Health Initiative Observational Study.
Chen Z; Maricic M; Bassford TL; Pettinger M; Ritenbaugh C; Lopez AM; Barad DH; Gass M; Leboff MS
Arch Intern Med; 2005 Mar; 165(5):552-8. PubMed ID: 15767532
[TBL] [Abstract][Full Text] [Related]
14. Predicting risk of breast cancer in postmenopausal women by hormone receptor status.
Chlebowski RT; Anderson GL; Lane DS; Aragaki AK; Rohan T; Yasmeen S; Sarto G; Rosenberg CA; Hubbell FA;
J Natl Cancer Inst; 2007 Nov; 99(22):1695-705. PubMed ID: 18000216
[TBL] [Abstract][Full Text] [Related]
15. Statin use and risk of colorectal cancer.
Coogan PF; Smith J; Rosenberg L
J Natl Cancer Inst; 2007 Jan; 99(1):32-40. PubMed ID: 17202111
[TBL] [Abstract][Full Text] [Related]
16. Statin but not non-statin lipid-lowering drugs decrease fracture risk: a nation-wide case-control study.
Rejnmark L; Vestergaard P; Mosekilde L
Calcif Tissue Int; 2006 Jul; 79(1):27-36. PubMed ID: 16868664
[TBL] [Abstract][Full Text] [Related]
17. The association between 3-hydroxy-3-methylglutaryl conenzyme A inhibitor use and breast carcinoma risk among postmenopausal women: a case-control study.
Boudreau DM; Gardner JS; Malone KE; Heckbert SR; Blough DK; Daling JR
Cancer; 2004 Jun; 100(11):2308-16. PubMed ID: 15160333
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer and nonsteroidal anti-inflammatory drugs: prospective results from the Women's Health Initiative.
Harris RE; Chlebowski RT; Jackson RD; Frid DJ; Ascenseo JL; Anderson G; Loar A; Rodabough RJ; White E; McTiernan A;
Cancer Res; 2003 Sep; 63(18):6096-101. PubMed ID: 14522941
[TBL] [Abstract][Full Text] [Related]
19. Statins and the risk of lung, breast, and colorectal cancer in the elderly.
Setoguchi S; Glynn RJ; Avorn J; Mogun H; Schneeweiss S
Circulation; 2007 Jan; 115(1):27-33. PubMed ID: 17179016
[TBL] [Abstract][Full Text] [Related]
20. Association of aspirin and nonaspirin nonsteroidal anti-inflammatory drugs with cancer incidence and mortality.
Bardia A; Ebbert JO; Vierkant RA; Limburg PJ; Anderson K; Wang AH; Olson JE; Vachon CM; Cerhan JR
J Natl Cancer Inst; 2007 Jun; 99(11):881-9. PubMed ID: 17551148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
